Medicine

Amoxicillin	Mefloquine
Acetaminophen	Melatonin
Chloroquine	Metronidazol
Ciprofloxacin	Penicillin
Doxycycline	Proguanil
Electrolyte Solution	Quinine
Erythromycin	Scopolamine
Fluconazole	Sulfadoxine and pyrimethamine combination
Hydrocortison creme	Sulfamethoxazole
Loperamide	Warfarin

Travel Medicine Resource:

S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole.
Warrilow AG, Mullins JG, Hull CM, Parker JE, Lamb DC, Kelly DE, Kelly SL.
Antimicrob Agents Chemother. 2012 Apr;56(4):2099-107. Epub 2012 Jan 17
Targeted treatment of invasive fungal infections accelerates healing of foot wounds in patients with Type 2 diabetes.
Chellan G, Neethu K, Varma AK, Mangalanandan TS, Shashikala S, Dinesh KR, Sundaram KR, Varma N, Jayakumar RV, Bal A, Kumar H.
Diabet Med. 2012 Jan 16. doi: 10.1111/j.1464-5491.2012.03574.x. [Epub ahead of print
Susceptibilities of Candida albicans Mouth Isolates to Antifungal Agents, Essentials Oils and Mouth Rinses.
Carvalhinho S, Costa AM, Coelho AC, Martins E, Sampaio A.
Mycopathologia. 2012 Jan 14. [Epub ahead of print
Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis.
Ye F, Xie JX, Zeng QS, Chen GQ, Zhong SQ, Zhong NS.
Lung. 2012 Jun;190(3):339-46. Epub 2012 Jan 14
Time to positivity of blood cultures of different Candida species causing fungaemia.
Lai CC, Wang CY, Liu WL, Huang YT, Hsueh PR.
J Med Microbiol. 2012 May;61(Pt 5):701-4. Epub 2012 Jan 13
Usefulness of capability indices in the framework of analytical methods validation.
Bouabidi A, Ziemons E, Marini R, Hubert C, Talbi M, Bouklouze A, Bourichi H, El Karbane M, Boulanger B, Hubert P, Rozet E.
Anal Chim Acta. 2012 Feb 10;714:47-56. Epub 2011 Dec 6
Cotrimoxazole enhances the in vitro susceptibility of Coccidioides posadasii to antifungals.
Cordeiro Rde A, Astete-Medrano DJ, Marques FJ, Andrade HT, Perdigão Neto LV, Tavares JL, de Lima RA, Patoilo KK, Monteiro AJ, Brilhante RS, Rocha MF, de Camargo ZP, Sidrim JJ.
Mem Inst Oswaldo Cruz. 2011 Dec;106(8):1045-8
A mutation in intracellular loop 4 affects the drug-efflux activity of the yeast multidrug resistance ABC transporter Pdr5p.
Guo X, Li J, Wang T, Liu Z, Chen X, Li Y, Gu Z, Mao X, Guan W, Li Y.
PLoS One. 2012;7(1):e29520. Epub 2012 Jan 6
Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot.
Daali Y, Samer C, Déglon J, Thomas A, Chabert J, Rebsamen M, Staub C, Dayer P, Desmeules J.
Clin Pharmacol Ther. 2012 Mar;91(3):489-96. doi: 10.1038/clpt.2011.247. Epub 2012 Jan 11
A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.
Mandras N, Roana J, Tullio V, Allizond V, Banche G, Scalas D, Fucale G, Cuffini AM.
J Chemother. 2011 Dec;23(6):379-80. No abstract available.
Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K; for the Antifungal Susceptibility Testing (AFST) Study Group.
Mycoses. 2012 May;55(3):e124-e137. doi: 10.1111/j.1439-0507.2011.02165.x. Epub 2012 Jan 11
Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.
Danby CS, Boikov D, Rautemaa-Richardson R, Sobel JD.
Antimicrob Agents Chemother. 2012 Mar;56(3):1403-6. Epub 2012 Jan 9
Fixed drug eruption due to fluconazole.
Beecker J, Colantonio S.
CMAJ. 2012 Apr 3;184(6):675. Epub 2012 Jan 9. No abstract available.
Cinnamic aldehydes affect hydrolytic enzyme secretion and morphogenesis in oral Candida isolates.
Shreaz S, Bhatia R, Khan N, Maurya IK, Ahmad SI, Muralidhar S, Manzoor N, Khan LA.
Microb Pathog. 2012 May;52(5):251-8. Epub 2011 Dec 20
Determination of antifungal susceptibility patterns among the clinical isolates of Candida species.
Zomorodian K, Rahimi MJ, Pakshir K, Motamedi M, Ghiasi MR, Rezashah H.
J Glob Infect Dis. 2011 Oct;3(4):357-60
Candida dubliniensis endophthalmitis: first case in North America.
Espinosa-Heidmann DG, McMillan BD, Lasala PR, Stanley J, Larzo CR.
Int Ophthalmol. 2012 Feb;32(1):41-5. Epub 2012 Jan 6
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.
O'Sullivan AK, Weinstein MC, Pandya A, Thompson D, Langston AA, Perfect JR, Papadopoulos G.
Am J Health Syst Pharm. 2012 Jan 15;69(2):149-56
A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
Hayama K, Ishibashi H, Ishijima SA, Niimi K, Tansho S, Ono Y, Monk BC, Holmes AR, Harding DR, Cannon RD, Abe S.
FEMS Microbiol Lett. 2012 Mar;328(2):130-7. doi: 10.1111/j.1574-6968.2011.02490.x. Epub 2012 Jan 16
Proton-pumping-ATPase-targeted antifungal activity of cinnamaldehyde based sulfonyl tetrazoles.
Shreaz S, Wani MY, Ahmad SR, Ahmad SI, Bhatia R, Athar F, Nikhat M, Khan LA.
Eur J Med Chem. 2012 Feb;48:363-70. Epub 2011 Dec 9
Vertically Transmitted HIV Infection Having First Clinical Manifestations at 13 y of Age.
Sagar A, Vasudevan B.
Indian J Pediatr. 2011 Dec 29. [Epub ahead of print
First Prev 5 6 7 8 9 10 11 12 13 Next Last 432/8628 Jump: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432

Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment. All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.